RecruitingNot ApplicableNCT06639360
Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke
Sponsor
Xijing Hospital
Enrollment
60 participants
Start Date
Aug 2, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This is a multicenter, randomized, double-blind, sham-controlled trial, to determine the efficacy and safety of cTBS in treating patients with acute ischemic stroke after endovascular treatment.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria7
- Patients with acute anterior circulation ischemic stroke aged between 18 and 80 years old.
- Imaging suggests that the infarction is caused by occlusion of the terminal portion of the internal carotid artery or the M1/M2 segment of the middle cerebral artery.
- A head CT within 24 hours of onset indicates an ASPECT score ≥6, and meets the guideline-recommended criteria for thrombectomy.
- Pre-stroke mRS score is ≤1.
- NIHSS score before thrombectomy is between 6 and 25.
- With vascular recanalization of mTICI \> 2b/3.
- Informed consent form signed.
Exclusion Criteria9
- Patients with contraindications to TMS treatment, such as those with metallic foreign objects in the head, pacemakers, implantable drug pumps, cochlear implants, etc.;
- Patients with epilepsy, increased intracranial pressure, tumors, acute cerebral hemorrhage, or other severe neurological diseases, and those with severe functional impairment of organs such as the heart, liver, and kidneys;
- Head CT/MRI indicates midline shift or significant mass effect, or patients planned for surgical intervention;
- Head CT/MRI suggests acute cerebral infarction in both sides;
- Patients who are pregnant or breastfeeding;
- Patients with severe mental disorders or dementia who cannot cooperate with follow-up;
- Patients with other severe diseases resulting in an expected survival of less than 90 days;
- Patients who are participating in other interventional clinical studies within 30 days before the start of this study or after the onset of this condition;
- Patients who cannot cooperate with informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICETranscranial Magnetic Stimulation Active
The patients will be treated with cTBS and usual medical treatment after endovascular treatment
DEVICETranscranial Magnetic Stimulation Sham
The patients will be treated with sham-cTBS and usual medical treatment after endovascular treatment
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06639360
Related Trials
Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia
NCT067269411 location
CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke
NCT050513971 location
Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
NCT060756281 location
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
NCT060944787 locations
The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)
NCT052471251 location